Esra Pancar Yuksel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Esra Pancar Yuksel has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Fatma Aydin
Dermatology Department, Faculty of Medicine, Ondokuz Mayis University, Turkey
6 shared publications- Nilgün Şentürk
Department of Dermatology, Ondokuz Mayis University, Samsun, Turkey
5 shared publications - Fatma Aydın
Department of Dermatology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Türkiye
4 shared publications - Gokhan Sahin
Department of Dermatology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Türkiye
4 shared publications Ahmet Yasar Turanli
Department of Dermatology, Ondokuz Mayis University SamsunTurkey
3 shared publicationsMüge Güler Özden
3 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7601
Cardiometabolic Inflammation in Vitiligo: Association with Metabolic Syndrome and Inflammatory Biomarkers
Background: Vitiligo, previously considered a localized skin disease, is now regarded as a systemic condition due to its association with autoimmune and metabolic abnormalities. The relationship between metabolic syndrome (MetS) and vitiligo is not clearly established. Chronic inflammation and oxidative stress may also contribute to inflammation-related cardiometabolic processes, even in the absence of MetS. Objectives: To investigate MetS components and inflammatory biomarkers (TNF-α, IL-6, GDF-15, and CCL-7) in patients with vitiligo without comorbidities and to compare the findings with healthy individuals. Methods: In this case–control study, 43 patients with vitiligo and 43 frequency-matched controls (18–65 years) were included. Participants with systemic diseases, smoking or alcohol use, or medications affecting metabolic parameters were excluded. Disease severity and activity were assessed using VASI, BSA, and VIDA scores. Anthropometric data, blood pressure, and laboratory parameters were recorded. Serum biomarker levels were measured by ELISA. Results: The two groups were similar in terms of age and sex. Systolic blood pressure was higher in the vitiligo group (P=0.011), whereas other metabolic parameters and MetS prevalence were comparable. Longer disease duration was associated with the presence of MetS (P=0.008). TNF-α, IL-6, GDF-15, and CCL-7 levels were significantly higher in patients than controls. Among these, GDF-15 and CCL-7 were associated with disease activity, while TNF-α and IL-6 were not. Multivariable regression analysis demonstrated that GDF-15 remained independently associated with vitiligo after adjusting for age, sex, and BMI, whereas the association with CCL-7 was no longer statistically significant. Conclusion: MetS prevalence was not increased in vitiligo; however, elevated inflammatory biomarkers may reflect inflammation-related cardiometabolic processes. After adjusting for age, sex, and BMI, GDF-15 remained independently associated with vitiligo, whereas the association with CCL-7 was no longer statistically significant.
- 29 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7601
Open AccessCardiometabolic Inflammation in Vitiligo: Association with Metabolic Syndrome and Inflammatory Biomarkers
Background: Vitiligo, previously considered a localized skin disease, is now regarded as a systemic condition due to its association with autoimmune and metabolic abnormalities. The relationship between metabolic syndrome (MetS) and vitiligo is not clearly established. Chronic inflammation and oxidative stress may also contribute to inflammation-related cardiometabolic processes, even in the absence of MetS. Objectives: To investigate MetS components and inflammatory biomarkers (TNF-α, IL-6, GDF-15, and CCL-7) in patients with vitiligo without comorbidities and to compare the findings with healthy individuals. Methods: In this case–control study, 43 patients with vitiligo and 43 frequency-matched controls (18–65 years) were included. Participants with systemic diseases, smoking or alcohol use, or medications affecting metabolic parameters were excluded. Disease severity and activity were assessed using VASI, BSA, and VIDA scores. Anthropometric data, blood pressure, and laboratory parameters were recorded. Serum biomarker levels were measured by ELISA. Results: The two groups were similar in terms of age and sex. Systolic blood pressure was higher in the vitiligo group (P=0.011), whereas other metabolic parameters and MetS prevalence were comparable. Longer disease duration was associated with the presence of MetS (P=0.008). TNF-α, IL-6, GDF-15, and CCL-7 levels were significantly higher in patients than controls. Among these, GDF-15 and CCL-7 were associated with disease activity, while TNF-α and IL-6 were not. Multivariable regression analysis demonstrated that GDF-15 remained independently associated with vitiligo after adjusting for age, sex, and BMI, whereas the association with CCL-7 was no longer statistically significant. Conclusion: MetS prevalence was not increased in vitiligo; however, elevated inflammatory biomarkers may reflect inflammation-related cardiometabolic processes. After adjusting for age, sex, and BMI, GDF-15 remained independently associated with vitiligo, whereas the association with CCL-7 was no longer statistically significant.
- Open Access
- 19 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7601
Cardiometabolic Inflammation in Vitiligo: Association with Metabolic Syndrome and Inflammatory Biomarkers
Background: Vitiligo, previously considered a localized skin disease, is now regarded as a systemic condition due to its association with autoimmune and metabolic abnormalities. The relationship between metabolic syndrome (MetS) and vitiligo is not clearly established. Chronic inflammation and oxidative stress may also contribute to inflammation-related cardiometabolic processes, even in the absence of MetS. Objectives: To investigate MetS components and inflammatory biomarkers (TNF-α, IL-6, GDF-15, and CCL-7) in patients with vitiligo without comorbidities and to compare the findings with healthy individuals. Methods: In this case–control study, 43 patients with vitiligo and 43 frequency-matched controls (18–65 years) were included. Participants with systemic diseases, smoking or alcohol use, or medications affecting metabolic parameters were excluded. Disease severity and activity were assessed using VASI, BSA, and VIDA scores. Anthropometric data, blood pressure, and laboratory parameters were recorded. Serum biomarker levels were measured by ELISA. Results: The two groups were similar in terms of age and sex. Systolic blood pressure was higher in the vitiligo group (P=0.011), whereas other metabolic parameters and MetS prevalence were comparable. Longer disease duration was associated with the presence of MetS (P=0.008). TNF-α, IL-6, GDF-15, and CCL-7 levels were significantly higher in patients than controls. Among these, GDF-15 and CCL-7 were associated with disease activity, while TNF-α and IL-6 were not. Multivariable regression analysis demonstrated that GDF-15 remained independently associated with vitiligo after adjusting for age, sex, and BMI, whereas the association with CCL-7 was no longer statistically significant. Conclusion: MetS prevalence was not increased in vitiligo; however, elevated inflammatory biomarkers may reflect inflammation-related cardiometabolic processes. After adjusting for age, sex, and BMI, GDF-15 remained independently associated with vitiligo, whereas the association with CCL-7 was no longer statistically significant.
- 19 October 2026
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 16 (4) , 7601
Open AccessCardiometabolic Inflammation in Vitiligo: Association with Metabolic Syndrome and Inflammatory Biomarkers
Background: Vitiligo, previously considered a localized skin disease, is now regarded as a systemic condition due to its association with autoimmune and metabolic abnormalities. The relationship between metabolic syndrome (MetS) and vitiligo is not clearly established. Chronic inflammation and oxidative stress may also contribute to inflammation-related cardiometabolic processes, even in the absence of MetS. Objectives: To investigate MetS components and inflammatory biomarkers (TNF-α, IL-6, GDF-15, and CCL-7) in patients with vitiligo without comorbidities and to compare the findings with healthy individuals. Methods: In this case–control study, 43 patients with vitiligo and 43 frequency-matched controls (18–65 years) were included. Participants with systemic diseases, smoking or alcohol use, or medications affecting metabolic parameters were excluded. Disease severity and activity were assessed using VASI, BSA, and VIDA scores. Anthropometric data, blood pressure, and laboratory parameters were recorded. Serum biomarker levels were measured by ELISA. Results: The two groups were similar in terms of age and sex. Systolic blood pressure was higher in the vitiligo group (P=0.011), whereas other metabolic parameters and MetS prevalence were comparable. Longer disease duration was associated with the presence of MetS (P=0.008). TNF-α, IL-6, GDF-15, and CCL-7 levels were significantly higher in patients than controls. Among these, GDF-15 and CCL-7 were associated with disease activity, while TNF-α and IL-6 were not. Multivariable regression analysis demonstrated that GDF-15 remained independently associated with vitiligo after adjusting for age, sex, and BMI, whereas the association with CCL-7 was no longer statistically significant. Conclusion: MetS prevalence was not increased in vitiligo; however, elevated inflammatory biomarkers may reflect inflammation-related cardiometabolic processes. After adjusting for age, sex, and BMI, GDF-15 remained independently associated with vitiligo, whereas the association with CCL-7 was no longer statistically significant.
- Open Access
- 5 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 396
Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
Background/Objectives: Alopecia areata is an autoimmune disorder characterized by nonscarring hair loss and systemic immune dysregulation. Hematological indices such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), mean platelet volume (MPV), systemic immune-inflammation index (SII), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) have been associated with inflammatory activity in dermatologic diseases. This study aimed to compare systemic inflammatory markers among patients with severe and mild alopecia areata and healthy controls, and to explore longitudinal changes in these markers in patients with severe disease who achieved clinical improvement following Janus kinase (JAK) inhibitor therapy. Methods: This retrospective cohort study included 129 participants: 43 patients with severe alopecia areata (SALT ≥ 50) treated with JAK inhibitors who achieved documented clinical improvement, 43 patients with mild disease (SALT ≤ 20), and 43 age- and sex-matched healthy controls. Hematological inflammatory markers, including red cell distribution width (RDW), MPV, MLR, NLR, PLR, SII, ESR, and CRP, were compared across groups. In patients with severe disease, longitudinal changes were assessed at baseline, three months after treatment initiation, and at the time of documented clinical improvement. Results: MLR, NLR, PLR, SII, and ESR levels were significantly higher in the severe group compared with mild cases and controls, while RDW, MPV, and CRP showed no significant differences. Among patients with severe alopecia areata who achieved clinical improvement following JAK inhibitor therapy, NLR and SII decreased significantly over time. MLR, PLR, and CRP also showed reductions during follow-up, while ESR and RDW remained unchanged. Conclusions: Systemic inflammatory markers are elevated in severe alopecia areata compared with mild disease and healthy controls. In patients who achieved clinical improvement with JAK inhibitor therapy, several inflammatory indices demonstrated longitudinal changes. These findings are exploratory and suggest an association between systemic inflammation, disease severity, and clinical improvement rather than definitive predictive biomarkers.
- 5 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 396
Open AccessSystemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
Background/Objectives: Alopecia areata is an autoimmune disorder characterized by nonscarring hair loss and systemic immune dysregulation. Hematological indices such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), mean platelet volume (MPV), systemic immune-inflammation index (SII), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) have been associated with inflammatory activity in dermatologic diseases. This study aimed to compare systemic inflammatory markers among patients with severe and mild alopecia areata and healthy controls, and to explore longitudinal changes in these markers in patients with severe disease who achieved clinical improvement following Janus kinase (JAK) inhibitor therapy. Methods: This retrospective cohort study included 129 participants: 43 patients with severe alopecia areata (SALT ≥ 50) treated with JAK inhibitors who achieved documented clinical improvement, 43 patients with mild disease (SALT ≤ 20), and 43 age- and sex-matched healthy controls. Hematological inflammatory markers, including red cell distribution width (RDW), MPV, MLR, NLR, PLR, SII, ESR, and CRP, were compared across groups. In patients with severe disease, longitudinal changes were assessed at baseline, three months after treatment initiation, and at the time of documented clinical improvement. Results: MLR, NLR, PLR, SII, and ESR levels were significantly higher in the severe group compared with mild cases and controls, while RDW, MPV, and CRP showed no significant differences. Among patients with severe alopecia areata who achieved clinical improvement following JAK inhibitor therapy, NLR and SII decreased significantly over time. MLR, PLR, and CRP also showed reductions during follow-up, while ESR and RDW remained unchanged. Conclusions: Systemic inflammatory markers are elevated in severe alopecia areata compared with mild disease and healthy controls. In patients who achieved clinical improvement with JAK inhibitor therapy, several inflammatory indices demonstrated longitudinal changes. These findings are exploratory and suggest an association between systemic inflammation, disease severity, and clinical improvement rather than definitive predictive biomarkers.
- Open Access
Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
Background and Objectives: Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss and has been associated with systemic immune-inflammatory activity and potential cardiometabolic risk. This study aimed to evaluate cardiovascular risk markers—including ECG parameters, arterial stiffness indices, anthropometric measurements, and body composition—in patients with AA according to disease severity and duration, and to compare these findings with healthy controls. Materials and Methods: This case–control study included 50 AA patients (32 men, 18 women; mean age: 28.98 ± 9.81 years) and 50 healthy controls (30 men, 20 women; mean age: 28.00 ± 7.86 years). All participants underwent anthropometric and electrocardiographic evaluations. Body composition was assessed, and arterial stiffness was measured. Subgroup analyses were performed according to SALT score (mild vs. moderate-to-severe) and disease duration (≥10 years vs. Results: Heart rate was lower in AA patients compared with controls (mean difference −5.14 bpm; 95% CI −10.267 to −0.013). No significant differences were found between the groups regarding anthropometric variables, body composition, or arterial stiffness indices. Among AA patients, those with moderate-to-severe disease had significantly lower body fat mass (mean difference 4.95 kg; 95% CI 0.26 to 9.644) and lower visceral fat rating (mean difference 2.428 units; 95% CI 0.800 to 4.056) compared with mild AA. Conclusions: AA patients demonstrated lower heart rate and disease-severity-related alterations in body composition, although the clinical significance of these findings remains uncertain. Larger longitudinal studies are needed to clarify whether these subclinical differences translate into meaningful cardiovascular risk over time.
Open AccessEvaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
Background and Objectives: Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss and has been associated with systemic immune-inflammatory activity and potential cardiometabolic risk. This study aimed to evaluate cardiovascular risk markers—including ECG parameters, arterial stiffness indices, anthropometric measurements, and body composition—in patients with AA according to disease severity and duration, and to compare these findings with healthy controls. Materials and Methods: This case–control study included 50 AA patients (32 men, 18 women; mean age: 28.98 ± 9.81 years) and 50 healthy controls (30 men, 20 women; mean age: 28.00 ± 7.86 years). All participants underwent anthropometric and electrocardiographic evaluations. Body composition was assessed, and arterial stiffness was measured. Subgroup analyses were performed according to SALT score (mild vs. moderate-to-severe) and disease duration (≥10 years vs. Results: Heart rate was lower in AA patients compared with controls (mean difference −5.14 bpm; 95% CI −10.267 to −0.013). No significant differences were found between the groups regarding anthropometric variables, body composition, or arterial stiffness indices. Among AA patients, those with moderate-to-severe disease had significantly lower body fat mass (mean difference 4.95 kg; 95% CI 0.26 to 9.644) and lower visceral fat rating (mean difference 2.428 units; 95% CI 0.800 to 4.056) compared with mild AA. Conclusions: AA patients demonstrated lower heart rate and disease-severity-related alterations in body composition, although the clinical significance of these findings remains uncertain. Larger longitudinal studies are needed to clarify whether these subclinical differences translate into meaningful cardiovascular risk over time.
- Open Access
- 13 May 2020
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 10 (2) , 39
Increased Demodex Density in Patients Hospitalized for Worsening Heart Failure
Infection is an important factor leading to the exacerbation of heart failure (HF), resulting in hospitalization. Demodex species are obligatory parasites in human skin, and increased density was reported in immunocompromised patients. In this study, we aimed to investigate the Demodex density in hospitalized HF patients compared to that of healthy controls. Methods: This study included 36 HF patients and 36 age and sex-matched healthy controls. Five standardized biopsies were taken from the face of participants and assessed for Demodex by a light microscope. Results: At least one Demodex mite was detected in 20 HF patients and nine of the control group. The number of Demodex mites was significantly higher in the HF group (median 1; min. 0 and max. 10) compared to the control group (median 0; minimum. 0 and maximum. 3). Demodicidosis was positive in 14 of the HF patients. Demodicidosis was not detected in the control group. Conclusions: This study showed that Demodex positivity is more common in HF patients hospitalized for HF exacerbation. Demodicidosis should be considered in hospitalized HF patients.
- 13 May 2020
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 10 (2) , 39
Open AccessIncreased Demodex Density in Patients Hospitalized for Worsening Heart Failure
Infection is an important factor leading to the exacerbation of heart failure (HF), resulting in hospitalization. Demodex species are obligatory parasites in human skin, and increased density was reported in immunocompromised patients. In this study, we aimed to investigate the Demodex density in hospitalized HF patients compared to that of healthy controls. Methods: This study included 36 HF patients and 36 age and sex-matched healthy controls. Five standardized biopsies were taken from the face of participants and assessed for Demodex by a light microscope. Results: At least one Demodex mite was detected in 20 HF patients and nine of the control group. The number of Demodex mites was significantly higher in the HF group (median 1; min. 0 and max. 10) compared to the control group (median 0; minimum. 0 and maximum. 3). Demodicidosis was positive in 14 of the HF patients. Demodicidosis was not detected in the control group. Conclusions: This study showed that Demodex positivity is more common in HF patients hospitalized for HF exacerbation. Demodicidosis should be considered in hospitalized HF patients.
- Open Access
Pre-Treatment and Post-Treatment Demodex Densities in Patients under Immunosuppressive Treatments
Background and Objectives: Demodex species are common obligatory parasites and normally present in low number in human beings. Immunosuppression was suggested to be associated with increased density of Demodex mites. Systemic glucocorticoids, cyclosporine, methotrexate, and azathioprine are commonly used immunosuppressive agents. We aim to determine the pre- and post-treatment Demodex densities in patients receiving immunosuppressive therapy and compare with those of healthy subjects. Materials and Methods: Demodex density was investigated at the beginning, first, and third months of the immunosuppressive therapy in 45 patients who received methotrexate, cyclosporine, systemic steroid, or azathioprine treatments and in 45 healthy subjects at the same time as the patients. Five standardized skin surface biopsies were taken from cheeks, forehead, nose, and chin of the patients and control group. The presence of five or more parasites in 1 cm2 area was considered as positive. Results: Demodex test was negative at the beginning of the treatment in all patients. Demodex test was positive in one patient in the first and third months of treatment and in three patients only in the third month of treatment. In the control group, Demodex test was determined as positive in just one healthy individual at the beginning, first and third months of the study. When the patient and control groups were evaluated in terms of Demodex number, there was a statistically significant difference in Demodex density in patients treated with immunosuppressive treatment in the first and third months when compared with the control group (p < 0.05). Conclusion: Immunosuppressive treatment might increase the number of Demodex mites and demodicidosis should be kept in mind in patients on immunosuppressive treatment.
Open AccessPre-Treatment and Post-Treatment Demodex Densities in Patients under Immunosuppressive Treatments
Background and Objectives: Demodex species are common obligatory parasites and normally present in low number in human beings. Immunosuppression was suggested to be associated with increased density of Demodex mites. Systemic glucocorticoids, cyclosporine, methotrexate, and azathioprine are commonly used immunosuppressive agents. We aim to determine the pre- and post-treatment Demodex densities in patients receiving immunosuppressive therapy and compare with those of healthy subjects. Materials and Methods: Demodex density was investigated at the beginning, first, and third months of the immunosuppressive therapy in 45 patients who received methotrexate, cyclosporine, systemic steroid, or azathioprine treatments and in 45 healthy subjects at the same time as the patients. Five standardized skin surface biopsies were taken from cheeks, forehead, nose, and chin of the patients and control group. The presence of five or more parasites in 1 cm2 area was considered as positive. Results: Demodex test was negative at the beginning of the treatment in all patients. Demodex test was positive in one patient in the first and third months of treatment and in three patients only in the third month of treatment. In the control group, Demodex test was determined as positive in just one healthy individual at the beginning, first and third months of the study. When the patient and control groups were evaluated in terms of Demodex number, there was a statistically significant difference in Demodex density in patients treated with immunosuppressive treatment in the first and third months when compared with the control group (p < 0.05). Conclusion: Immunosuppressive treatment might increase the number of Demodex mites and demodicidosis should be kept in mind in patients on immunosuppressive treatment.
- 1 January 2020
- Published by Kare Publishing in Eurasian Journal of Medical Investigation
- Vol. 4 (1) , 123-125
Secondary Syphilis Presented with Oral Ulcers as the Great Imitator
Ejmi Eurasian Journal of Medical Investigation
- 1 January 2020
- Published by Kare Publishing in Eurasian Journal of Medical Investigation
- Vol. 4 (1) , 123-125
Secondary Syphilis Presented with Oral Ulcers as the Great Imitator
Ejmi Eurasian Journal of Medical Investigation
- Open Access
- 16 July 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (9) , 4284-4291
Perceived stress, life events, fatigue and temperament in patients with psoriasis
Objective: To evaluate the perceived stress, life events, fatigue and temperament profile in patients with psoriasis and to investigate the relationship between these factors. Methods: This cross-sectional study included patients with psoriasis and healthy control subjects. The two groups were compared regarding the number of life events, Perceived Stress Scale (PSS) and Multidimensional Assessment of Fatigue scores. The Temperament Evaluation of Memphis, Pisa, Paris and San Diego Autoquestionnaire was used to evaluate the personality traits among the two groups. Results: A total of 75 patients with psoriasis (mean ± SD age, 44.94 ± 13.62 years) and 75 healthy controls (mean ± SD age, 41.10 ± 8.89 years) were included in the study. A statistically significant difference was found between the two groups in terms of the presence of life events, PSS score, fatigue and temperament profiles. Patients with psoriasis with depressive, cyclothymic and anxious temperament profiles were found to have higher PSS scores. In the psoriasis group, the PSS scores were positively correlated with the number of life events. Conclusions: Stress and life events were found to be correlated with psoriasis. In the patients with psoriasis, depressive, cyclothymic and anxious temperament profiles seemed to be associated with higher perceived stress.
- 16 July 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (9) , 4284-4291
Open AccessPerceived stress, life events, fatigue and temperament in patients with psoriasis
Objective: To evaluate the perceived stress, life events, fatigue and temperament profile in patients with psoriasis and to investigate the relationship between these factors. Methods: This cross-sectional study included patients with psoriasis and healthy control subjects. The two groups were compared regarding the number of life events, Perceived Stress Scale (PSS) and Multidimensional Assessment of Fatigue scores. The Temperament Evaluation of Memphis, Pisa, Paris and San Diego Autoquestionnaire was used to evaluate the personality traits among the two groups. Results: A total of 75 patients with psoriasis (mean ± SD age, 44.94 ± 13.62 years) and 75 healthy controls (mean ± SD age, 41.10 ± 8.89 years) were included in the study. A statistically significant difference was found between the two groups in terms of the presence of life events, PSS score, fatigue and temperament profiles. Patients with psoriasis with depressive, cyclothymic and anxious temperament profiles were found to have higher PSS scores. In the psoriasis group, the PSS scores were positively correlated with the number of life events. Conclusions: Stress and life events were found to be correlated with psoriasis. In the patients with psoriasis, depressive, cyclothymic and anxious temperament profiles seemed to be associated with higher perceived stress.
- 1 July 2019
- Published by Elsevier in Microvascular Research
- Vol. 124, 51-53
Microvascular abnormalities in asymptomatic chronic smokers: A videocapillaroscopic study
- 1 July 2019
- Published by Elsevier in Microvascular Research
- Vol. 124, 51-53
Microvascular abnormalities in asymptomatic chronic smokers: A videocapillaroscopic study